RE FDA REJECTS M.S DRUG WITH POTENTIALLY SERIOUS SIDE EFFCT

A board to discuss the soon-to-be released drug Campath as a treatment for Multiple Sclerosis
Post Reply
User avatar
seeva
Family Elder
Posts: 505
Joined: Sun Jan 20, 2008 3:00 pm
Location: SYDNEY
Contact:

RE FDA REJECTS M.S DRUG WITH POTENTIALLY SERIOUS SIDE EFFCT

Post by seeva » Tue Mar 01, 2016 2:08 am

HI Friends please read
http://www.healthline.com/health-news/m ... als-010814
regards
seeva

User avatar
CureOrBust
Family Elder
Posts: 3367
Joined: Wed Jul 27, 2005 2:00 pm
Location: Sydney, Australia

Re: RE FDA REJECTS M.S DRUG WITH POTENTIALLY SERIOUS SIDE E

Post by CureOrBust » Tue Mar 01, 2016 3:32 am

seeva wrote:HI Friends please read
http://www.healthline.com/health-news/m ... als-010814
regards
Seva, please, please please copy and quote the first few paragraphs with any link you provide. Doing so may of highlighted that this report is actually from 2014. Lemtrada is not only approved in Australia, but it is also on the PBS (public funding)
FDA Rejects MS Drug with Potentially Serious Side Effects
Written by Jeri Burtchell | Published on January 8, 2014
Genzyme's MS drug Lemtrada falls short of FDA requirements.

Drugmaker Genzyme was dealt a major blow last week when its multiple sclerosis (MS) drug Lemtrada was rejected by the Food and Drug Administration (FDA). The FDA ruling cited the need for further trials to demonstrate the drug's effectiveness and safety. European regulators approved Lemtrada in September 2013.

Post Reply
  • Similar Topics
    Replies
    Views
    Last post